BARD1 Life Sciences Ltd
ASX:BD1
Balance Sheet
Balance Sheet Decomposition
BARD1 Life Sciences Ltd
BARD1 Life Sciences Ltd
Balance Sheet
BARD1 Life Sciences Ltd
| Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
0
|
0
|
2
|
3
|
1
|
1
|
8
|
7
|
5
|
|
| Cash |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
2
|
3
|
1
|
1
|
8
|
7
|
5
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
0
|
0
|
2
|
3
|
1
|
1
|
8
|
7
|
6
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
|
| Long-Term Investments |
15
|
4
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
|
| Total Assets |
16
N/A
|
4
-74%
|
3
-33%
|
2
-34%
|
3
+78%
|
1
-78%
|
1
+100%
|
8
+425%
|
7
-3%
|
34
+355%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+10%
|
2
+48%
|
0
-95%
|
0
+407%
|
0
+2%
|
0
-31%
|
0
+52%
|
1
+83%
|
4
+397%
|
|
| Equity | |||||||||||
| Common Stock |
60
|
60
|
60
|
62
|
7
|
7
|
9
|
17
|
19
|
52
|
|
| Retained Earnings |
46
|
56
|
59
|
60
|
4
|
6
|
8
|
10
|
13
|
23
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
15
N/A
|
3
-81%
|
1
-70%
|
2
+97%
|
3
+61%
|
0
-91%
|
1
+338%
|
7
+531%
|
6
-9%
|
29
+349%
|
|
| Total Liabilities & Equity |
16
N/A
|
4
-74%
|
3
-33%
|
2
-34%
|
3
+78%
|
1
-78%
|
1
+100%
|
8
+425%
|
7
-3%
|
34
+355%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
113
|
113
|
113
|
178
|
19
|
19
|
28
|
42
|
46
|
80
|
|